Stromal remodeling and SPARC (secreted protein acid rich in cysteine) expression in invasive ductal carcinomas of the breast

Virchows Archiv

Volumn 446, Issue 5, 2005, Pages 532-536

  Barth, Peter J ^a   Moll, Roland ^a   Ramaswamy, Annette ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Breast; CD34; Invasive ductal carcinoma; SPARC; Stroma

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD34 ANTIGEN; OSTEONECTIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BREAST CARCINOMA; BREAST DUCT; CANCER INVASION; CONTROLLED STUDY; CYTOPLASM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NEEDLE BIOPSY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA CELL;

ACTINS; ACTIVIN RECEPTORS, TYPE I; ANTIGENS, CD34; BIOPSY; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; OSTEONECTIN; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; STROMAL CELLS;

EID: 21244471421     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-005-1256-9     Document Type: Article

References (27)

1. Abe R, Donnelly SC, Peng T, Bucala R, Metz CN (2001) Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 166:7556-7562
2. Abe K, Hibino T, Mishima H, Shimomura Y (2004) The cytokine regulation of SPARC production by rabbit corneal epithelial cells and fibroblasts in vitro. Cornea 23:172-179
3. + fibrocytes in invasive ductal carcinoma, ductal carcinoma in situ, and benign breast lesions. Virchows Arch 440:298-303
4. + fibrocytes in neoplastic and inflammatory pancreatic lesions. Virchows Arch 440:128-133
5. + fibrocytes in normal cervical stroma, cervical intraepithelial neoplasia III, and invasive squamous cell carcinoma of the cervix uteri. Virchows Arch 441:564-568
6. Barth PJ, Schenck zu Schweinsberg T, Ramaswamy A, Moll R (2004) CD34+fibrocytes, α-smooth muscle antigen-positive myofibroblasts, and CD117 expression in the stroma of invasive squamous cell carcinomas of the oral cavity, pharynx, and larynx. Virchows Arch 444:231-234
7. Bradshaw AD, Sage EH (2001) SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury. J Clin Invest 107:1049-1054
8. Bucala R, Spiegel LA, Chesney J, Hogan M, Cerami A (1994) Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1:71-81
9. Chauhan H, Abraham A, Phillips JR, Pringle JH, Walker RA, Jones JL (2003) There is more than one kind of myofibroblast: analysis of CD34 expression hi benign, in situ, and invasive breast lesions. J Clin Pathol 56:271-276
10. Chesney J, Bacher M, Bender A, Bucala R (1997) The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ. Proc Natl Acad Sci USA 94:6307-6312
11. Chesney J, Metz C, Stavitsky AB, Bacher M, Bucala R (1998) Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes. J Immunol 160:419-425
12. Espana EM, Kawakita T, Liu CY, Tseng SC (2004) CD-34 expression by cultured human keratocytes is downregulated during myofibroblast differentiation induced by TGF-beta1. Invest Ophthalmol Vis Sci 45:2985-2991
13. Framson PE, Sage EH (2004) SPARC and tumor growth: where the seed meets the soil? J Cell Biochem 92:679-690
14. Hartlapp I, Abe R, Saeed RW, Peng T, Voelter W, Bucala R, Metz CN (2001) Fibrocytes induce an angiogenic phenotype in cultured endothelial cells and promote angiogenesis in vivo. FASEB J 15:2215-2224
15. Iacobuzio-Donahue CA, Argani P, Hempen PM, Jones J, Kern SE (2002) The desmoplastic response to infiltrating breast carcinoma: gene expression at the site of primary invasion and implications for comparisons between tumor types. Cancer Res 62:5351-5357
16. Khan AI, Landis RC, Malhotra R (2003) L-Selectin ligands in lymphoid tissues and models of inflammation. Inflammation 27:265-280
17. Murphy-Ullrich JE (2001) The de-adhesive activity of matricellular proteins: is intermediate cell adhesion an adaptive state? J Clin Invest 107:785-790
18. Nakayama H, Enzan H, Miyazaki E, Kuroda N, Naruse K, Hiroi M (2000) Differential expression of CD34 in normal colorectal tissue, peritumoral inflammatory tissue, and tumour stroma. J Clin Pathol 53:626-629
19. Nakayama H, Enzan H, Miyazaki E, Kuroda N, Naruse K, Kiyoku H, Toi M, Hiroi M (2001) CD34 positive stromal cells in gastric adenocarcinomas. J Clin Pathol 54:846-848
20. Phillips RJ, Burdick MD, Hong K, Lutz MA, Murray LA, Xue YY, Belperio JA, Keane MP, Strieter RM (2004) Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest 114:438-446
21. Porter PL, Sage EH, Lane TF, Funk SE, Gown AM (1995) Distribution of SPARC in normal and neoplastic human tissue. J Histochem Cytochem 43:791-800
22. + fibrocytes in tubular carcinomas and radial scars of the breast. Virchows Arch 443:536-540
23. Reed MJ, Vernon RB, Abrass IB, Sage EH (1994) TGF-beta 1 induces the expression of type I collagen and SPARC, and enhances contraction of collagen gels, by fibroblasts from young and aged donors. J Cell Physiol 158:169-179
24. Ryu B, Jones J, Hollingsworth MA, Hruban RH, Kern SE (2001) Invasion-specific genes in malignancy: serial analysis of gene expression comparisons of primary and passaged cancers. Cancer Res 61:1833-1838
25. Schiemann BJ, Neil JR, Schiemann WP (2003) SPARC inhibits epithelial cell proliferation in part through stimulation of the transforming growth factor-β-signaling system. Mol Biol Cell 14:3977-3988
26. Schmidt M, Sun G, Stacey MA, Mori L, Mattoli S (2003) Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J Immunol 171:380-389
27. Soma L, LiVolsi VA, Baloch ZW (2001) Dendritic interstitial and myofibroblastic cells at the border of salivary gland tumors. Arch Pathol Lab Med 125:232-236